Literature DB >> 27785767

On Designs for Vaccine Surveillance.

Robert W Platt1.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 27785767     DOI： 10.1007/s40264-016-0457-2

Source DB:  PubMed          Journal:  Drug Saf        ISSN： 0114-5916            Impact factor:   5.606


× No keyword cloud information.
  7 in total

1.  Postmarketing surveillance and adverse drug reactions: current perspectives and future needs.

Authors:  T Brewer; G A Colditz
Journal:  JAMA       Date:  1999-03-03       Impact factor: 56.272

Review 2.  Case-population studies in pharmacoepidemiology.

Authors:  Dolors Capellà; Consuelo Pedrós; Xavier Vidal; Joan-Ramon Laporte
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

3.  Semi-automated sensitivity analysis to assess systematic errors in observational data.

Authors:  Timothy L Lash; Aliza K Fink
Journal:  Epidemiology       Date:  2003-07       Impact factor: 4.822

Review 4.  Underuse of self-controlled designs in pharmacoepidemiology in electronic healthcare databases: a systematic review.

Authors:  Nathalie Gault; Johann Castañeda-Sanabria; Sylvie Guillo; Stéphanie Foulon; Florence Tubach
Journal:  Pharmacoepidemiol Drug Saf       Date:  2016-01-19       Impact factor: 2.890

Review 5.  Measuring Signal Detection Performance: Can We Trust Negative Controls and Do We Need Them?

Authors:  Jim Slattery
Journal:  Drug Saf       Date:  2016-05       Impact factor: 5.606

6.  Vaccine Case-Population: A New Method for Vaccine Safety Surveillance.

Authors:  Hélène Théophile; Nicholas Moore; Philip Robinson; Bernard Bégaud; Antoine Pariente
Journal:  Drug Saf       Date:  2016-12       Impact factor: 5.606

7.  Active surveillance for adverse events: the experience of the Vaccine Safety Datalink project.

Authors:  W Katherine Yih; Martin Kulldorff; Bruce H Fireman; Irene M Shui; Edwin M Lewis; Nicola P Klein; James Baggs; Eric S Weintraub; Edward A Belongia; Allison Naleway; Julianne Gee; Richard Platt; Tracy A Lieu
Journal:  Pediatrics       Date:  2011-04-18       Impact factor: 7.124
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.